OxyContin Maker Purdue Pharma Considering Bankruptcy
< Back to News
The OxyContin maker Purdue Pharma is reportedly considering bankruptcy protection to address legal liabilities. Plaintiffs have accused the company of flooding the market with addictive opioid drugs and misleading doctors and patients about the risks of these medications.
滥用: to abuse or misuse
诉讼: litigation
批准: approval
驳回: to reject or overrule
处方药: prescription medication
涉及: to be involved or related to
充斥着: to be full of or flood (negative connotation)
濫用: to abuse or misuse
訴訟: litigation
批准: approval
駁回: to reject or overrule
處方藥: prescription medication
涉及: to be involved or related to
充斥著: to be full of or flood (negative connotation)
据报道，奥施康定的生产商普渡制药正在考虑破产保护，以解决面临的诉讼责任。
目前大约有2,000起诉讼是针对该公司造成的阿片类药物滥用。
原告声称，普渡及其所有者萨克家族在主导欺骗性广告宣传活动的同时，让市场上充斥着令人上瘾的处方药。
美国疾病控制和预防中心的最新数据显示，2017年超过47,600例药物过量死亡涉及阿片类药物。
普渡称，美国食品和药物管理局批准了公司关于阿片类止痛药的警告标签。
6月，马萨诸塞州总检察长Maura Healey, 成为第一个起诉普渡制和萨克家族的原告。
Healey声称相关家族成员从误导性阿片类药物营销中获利42亿美元。
普渡 要求法官驳回此案。
如果普渡根据“美国破产法”第11章提交破产保护，这些法律诉讼将停止，公司将有机会在美国破产法官的监督下进一步谈判索赔问题。
據報導，奧施康定的生產商普渡 製藥正在考慮破產保護， 以解決面臨的訴訟責任。
目前大約有2，000起訴訟是針對該公司造成的阿片類藥物濫用。
原告聲稱，普渡及其所有者薩克家族在主導欺騙性廣告宣傳活動的同 時，讓市場上充斥著令人上癮的處方藥。
美國疾病控制和預防中心的最新數據顯示，2017年超過47,600例藥物過量死亡涉及阿片類藥物。
普渡稱，美國食品和藥物管理局批准了公司關於阿片類止痛藥的警告標籤。
6月，馬薩諸塞州總檢察長Maura Healey, 成為第一個起訴普渡和薩克勒家族的原告。
Healey聲稱相關家族成員從誤導性阿片類藥物營銷中獲利42億美元。
普渡要求法官駁回此案。
如果普渡根據“美國破產法”第11章提交破產保護，這些法律訴訟將停止，公司將有機會在美國破產法官的監督下進一步談判索賠問題。
Purdue Pharma, maker of OxyContin, is reportedly considering bankruptcy protection to address liabilities faced in court.
Approximately 2,000 lawsuits have been filed against the company regarding its role in the opioid epidemic.
Plaintiffs claim that Purdue and its owner, the Sackler family, have flooded the market with highly addictive prescription drugs while leading deceptive advertising campaigns.
The latest data from the US Centers for Disease Control and Prevention indicate that over 47,600 of overdose deaths in 2017 involved opioids.
Purdue alleges that the United States Food and Drug Administration approved their warning labels on opioid painkillers.
In June, the Massachusetts attorney general, Maura Healey, became the first plaintiff to sue both Purdue and the Sackler family.
Healey claimed that the family members reaped $4.2 billion as a result of misleading opioid marketing.
Purdue has asked a judge to dismiss the case.
If Purdue files for Chapter 11 protection under the United States Bankruptcy Code, these legal proceedings would halt, and the company would have an opportunity to further negotiate claims under the supervision of a US bankruptcy judge.
WE WANT TO HEAR FROM YOU!
Feedback